Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2013/052518external-prioritypatent/WO2013117683A1/fr
Application filed by Aventis Pharma SafiledCriticalAventis Pharma Sa
Publication of MA35899B1publicationCriticalpatent/MA35899B1/fr
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La présente invention concerne le composé de formule (i): qui peut être sous la forme d'une base anhydre, un hydrate ou un solvate, en vue de son utilisation pour le traitement de cancers pédiatrique.
MA37270A2012-02-102014-08-07Nouvelles utilisations pédiatriques du cabazitaxel
MA35899B1
(fr)